Ozempic (Semaglutide)

Service Description

Ozempic (Semaglutide) is a FDA- Approved medication for the treatment of weightless. Rigorous clinical studies have shown significant weight loss, as well as improved blood glucose levels, in patients receiving this treatment. Ozempic is a GLP-1a drug, that activates GLP-1 receptors in the pancreas, thereby improving the release of glucagon. This combination of actions leads to homeostasis of glucose, which triggers the burning of fat storage for energy. (Provider consultation ($150) and recent labs needed prior to administration. First shot is included in provider consultation.)